Peter I. Pillans

3.1k total citations
93 papers, 2.2k citations indexed

About

Peter I. Pillans is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Peter I. Pillans has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Transplantation, 21 papers in Pediatrics, Perinatology and Child Health and 16 papers in Infectious Diseases. Recurrent topics in Peter I. Pillans's work include Renal Transplantation Outcomes and Treatments (25 papers), Pharmacological Effects and Toxicity Studies (14 papers) and HIV/AIDS drug development and treatment (12 papers). Peter I. Pillans is often cited by papers focused on Renal Transplantation Outcomes and Treatments (25 papers), Pharmacological Effects and Toxicity Studies (14 papers) and HIV/AIDS drug development and treatment (12 papers). Peter I. Pillans collaborates with scholars based in Australia, United Kingdom and New Zealand. Peter I. Pillans's co-authors include Paul J. Taylor, Paul Salm, Andrew J. Finch, Ian Scott, David M Coulter, Susan E. Tett, David W. Johnson, David W. Mudge, Paul Kubler and Bronwyn Atcheson and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Peter I. Pillans

91 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter I. Pillans Australia 29 597 329 307 298 294 93 2.2k
Nicolas Picard France 29 968 1.6× 697 2.1× 196 0.6× 207 0.7× 200 0.7× 81 2.5k
Jung Mi Oh South Korea 24 458 0.8× 379 1.2× 130 0.4× 139 0.5× 108 0.4× 139 1.7k
Manuel Haschke Switzerland 29 209 0.4× 394 1.2× 372 1.2× 386 1.3× 145 0.5× 113 3.2k
Penny Lewis United Kingdom 22 343 0.6× 233 0.7× 280 0.9× 689 2.3× 146 0.5× 83 2.8k
Frieder Keller Germany 29 208 0.3× 294 0.9× 467 1.5× 89 0.3× 128 0.4× 160 2.8k
Robert L. Page United States 36 294 0.5× 359 1.1× 412 1.3× 828 2.8× 170 0.6× 147 4.9k
Brian S. Decker United States 18 348 0.6× 520 1.6× 194 0.6× 65 0.2× 135 0.5× 44 1.6k
David Czock Germany 23 151 0.3× 255 0.8× 435 1.4× 132 0.4× 109 0.4× 111 2.3k
Antonio J. Carcas Spain 22 132 0.2× 306 0.9× 353 1.1× 55 0.2× 146 0.5× 116 1.7k
Christina L. Aquilante United States 26 93 0.2× 468 1.4× 210 0.7× 87 0.3× 103 0.4× 87 2.3k

Countries citing papers authored by Peter I. Pillans

Since Specialization
Citations

This map shows the geographic impact of Peter I. Pillans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter I. Pillans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter I. Pillans more than expected).

Fields of papers citing papers by Peter I. Pillans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter I. Pillans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter I. Pillans. The network helps show where Peter I. Pillans may publish in the future.

Co-authorship network of co-authors of Peter I. Pillans

This figure shows the co-authorship network connecting the top 25 collaborators of Peter I. Pillans. A scholar is included among the top collaborators of Peter I. Pillans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter I. Pillans. Peter I. Pillans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isoardi, Katherine, et al.. (2019). Neurotoxicity in chronic lithium poisoning. Internal Medicine Journal. 50(4). 427–432. 7 indexed citations
2.
Chan, Samuel, et al.. (2017). Phosphate binders in patients with chronic kidney disease. Australian Prescriber. 40(1). 9–14. 45 indexed citations
3.
Taylor, Paul J., et al.. (2011). Therapeutic drug monitoring of tacrolimus by liquid chromatography–tandem mass spectrometry: Is it truly a routine test?. Journal of Chromatography B. 883-884. 108–112. 24 indexed citations
4.
Stocker, Sophie L., Michael E. Franklin, John E. Anderson, et al.. (2010). Measurement of urinary oxypurinol by high performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 878(25). 2363–2368. 11 indexed citations
5.
Yelland, Michael, Christopher J. Poulos, Peter I. Pillans, et al.. (2009). N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain. Pain Medicine. 10(4). 754–761. 35 indexed citations
6.
Pillans, Peter I., et al.. (2009). Rare cause of dyspnoea. Internal Medicine Journal. 39(3). 197–199. 1 indexed citations
7.
Pillans, Peter I., et al.. (2009). Off‐label use of rituximab in a tertiary Queensland hospital. Internal Medicine Journal. 40(6). 443–452. 21 indexed citations
8.
Franklin, Michael E., Nigel W. Brown, J. Michael Tredger, et al.. (2007). The measurement of total and free mycophenolic acid by HPLC-Tandem mass spectrometry. Therapeutic Drug Monitoring. 29(4). 510–511. 1 indexed citations
9.
Kubler, Paul, et al.. (2004). Concordance between clopidogrel use and prescribing guidelines. Internal Medicine Journal. 34(12). 663–667. 7 indexed citations
10.
Taylor, J. Paul, et al.. (2004). The Measurement of Nicotine in Human Plasma by High-Performance Liquid Chromatography-Electrospray-Tandem Mass Spectrometry. Therapeutic Drug Monitoring. 26(5). 563–568. 15 indexed citations
11.
Pillans, Peter I., et al.. (2003). Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital. Internal Medicine Journal. 33(5-6). 225–228. 8 indexed citations
12.
Taylor, J. Paul, S. V. Lynch, Paul Kubler, Jane S. Allen, & Peter I. Pillans. (2003). The influence of atorvastatin on cyclosporin method for the measurement of cyclosporin pharmacokinetics in stable liver transplant recipients. Therapeutic Drug Monitoring. 25(4). 506–506. 5 indexed citations
13.
Salm, Paul, Paul J. Taylor, Stephen V. Lynch, & Peter I. Pillans. (2002). Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography–electrospray tandem mass spectrometry. Journal of Chromatography B. 772(2). 283–290. 28 indexed citations
14.
Coombes, Ian, et al.. (2001). Quality of Medication Ordering at a Large Teaching Hospital. The Australian Journal of Hospital Pharmacy. 31(2). 102–106. 22 indexed citations
15.
Willis, Charlene, Paul J. Taylor, Paul Salm, Susan E. Tett, & Peter I. Pillans. (2000). Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration???Time Curve in Adult Renal Transplant Patients. Therapeutic Drug Monitoring. 22(5). 549–554. 53 indexed citations
16.
Salm, Paul, et al.. (2000). Stability of Sirolimus (Rapamycin) in Whole Blood. Therapeutic Drug Monitoring. 22(4). 423–426. 13 indexed citations
17.
Willis, C., et al.. (1999). Evaluation of limited sampling strategies for the estimation of 12-hour Mycophenolic Acid. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
18.
Pillans, Peter I., et al.. (1999). Drug Usage Evaluation of Antimicrobial Therapy for Community‐Acquired Pneumonia. The Australian Journal of Hospital Pharmacy. 29(6). 317–320. 7 indexed citations
19.
Pillans, Peter I., et al.. (1989). Cyclophosphamide induced DNA strand breaks in mouse embryo cephalic tissue in vivo. Carcinogenesis. 10(1). 83–85. 15 indexed citations
20.
Pillans, Peter I., et al.. (1988). The effects of in vivo administration of teratogenic doses of vitamin A during the preimplantation period in the mouse. Teratology. 37(1). 7–11. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Picard Breakdown of academic impact, for papers by Jung Mi Oh Breakdown of academic impact, for papers by Manuel Haschke Breakdown of academic impact, for papers by Penny Lewis Breakdown of academic impact, for papers by Frieder Keller Breakdown of academic impact, for papers by Robert L. Page Breakdown of academic impact, for papers by Brian S. Decker Breakdown of academic impact, for papers by David Czock Breakdown of academic impact, for papers by Antonio J. Carcas Breakdown of academic impact, for papers by Christina L. Aquilante
Rankless by CCL
2026